1. Home
  2. XYLO vs VIVS Comparison

XYLO vs VIVS Comparison

Compare XYLO & VIVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XYLO
  • VIVS
  • Stock Information
  • Founded
  • XYLO 1999
  • VIVS 2007
  • Country
  • XYLO Israel
  • VIVS United States
  • Employees
  • XYLO N/A
  • VIVS N/A
  • Industry
  • XYLO
  • VIVS Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • XYLO
  • VIVS Health Care
  • Exchange
  • XYLO NYSE
  • VIVS Nasdaq
  • Market Cap
  • XYLO 3.8M
  • VIVS 3.6M
  • IPO Year
  • XYLO N/A
  • VIVS N/A
  • Fundamental
  • Price
  • XYLO $4.84
  • VIVS $1.84
  • Analyst Decision
  • XYLO
  • VIVS
  • Analyst Count
  • XYLO 0
  • VIVS 0
  • Target Price
  • XYLO N/A
  • VIVS N/A
  • AVG Volume (30 Days)
  • XYLO 1.5K
  • VIVS 71.5K
  • Earning Date
  • XYLO 06-17-2025
  • VIVS 06-13-2025
  • Dividend Yield
  • XYLO N/A
  • VIVS N/A
  • EPS Growth
  • XYLO N/A
  • VIVS N/A
  • EPS
  • XYLO N/A
  • VIVS N/A
  • Revenue
  • XYLO $29,858,000.00
  • VIVS $144,000.00
  • Revenue This Year
  • XYLO $279.19
  • VIVS $59.08
  • Revenue Next Year
  • XYLO N/A
  • VIVS $18.24
  • P/E Ratio
  • XYLO N/A
  • VIVS N/A
  • Revenue Growth
  • XYLO N/A
  • VIVS N/A
  • 52 Week Low
  • XYLO $2.70
  • VIVS $1.56
  • 52 Week High
  • XYLO $6.67
  • VIVS $21.96
  • Technical
  • Relative Strength Index (RSI)
  • XYLO 41.82
  • VIVS N/A
  • Support Level
  • XYLO $4.79
  • VIVS N/A
  • Resistance Level
  • XYLO $5.26
  • VIVS N/A
  • Average True Range (ATR)
  • XYLO 0.12
  • VIVS 0.00
  • MACD
  • XYLO -0.04
  • VIVS 0.00
  • Stochastic Oscillator
  • XYLO 10.20
  • VIVS 0.00

About XYLO XYLO TECHNOLOGIES LTD

Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in five segments namely, E-Commerce, Online Advertising & Internet Traffic Routing, Online Event Management, Corporate, and others. The company's geographical segments include the United States, Europe, Great Britain, Israel, Canada, Asia, and others.

About VIVS VivoSim Labs Inc. Common Stock

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.

Share on Social Networks: